Skip Navigation
  • The MHH
  • International office
  • Press
  • Emergency numbers
  • Patients & Visitors
    • Patients & Visitors
    • Admission as an emergency
    • Inpatient treatment
      • Inpatient treatment
      • Before your stay
      • During your stay
      • Ending your stay
    • Outpatient treatment
    • Important questions and answers
    • General information
      • General information
      • Dementia officer
      • Store passage
      • Teaching in the pediatric clinic
      • Directions
    • Patient Service Center PSC
      • Patient Service Center PSC
      • Contact
    • Patient advocate
  • Facilities & Departments
    • Facilities & Departments
    • Kliniken der MHH
    • Institutes of MHH
    • Clinical Departments and Institutes according to MHH centers
    • Interdisciplinary centers
    • Central facilities
  • Research
    • Research
    • Research foci
      • Research foci
      • COVID-19
      • BeoNet register
    • Core Research Units
      • Core Research Units
      • MeDIC
      • Hannover Unified Biobank (HUB)
      • Lasermikroskopie
      • Research Core Unit Electron Microscopy
    • Academic Career Development
      • Academic Career Development
      • Internal university performance promotion
    • Advisory Services
      • Advisory Services
      • DFG
    • Research Infrastructure
      • Research Infrastructure
      • Research information system
    • Dean of Research
    • Good Scientific Practice
      • Good Scientific Practice
      • Commission for Good Scientific Practice
      • Ombuds Office and Ombudsperson
    • Transparency in Research
    • Research Funding, Knowledge & Technology Transfer
      • Research Funding, Knowledge & Technology Transfer
      • Partners & Networks
      • For life scientists
      • For partners & investors
      • For startups and founders
    • Accident research
      • Accident research
      • What we do
      • You have been in contact with us
      • Science and research
      • Publications
  • Study & Teaching
    • Study & Teaching
    • Study programmes
    • Registrar's Office
      • Registrar's Office
      • Prospective students
      • Students
      • Dates & deadlines
      • Contact
    • Sayit anti-discrimination platform
    • MHH-Alumni e.V. - the alumni network
      • MHH-Alumni e.V. - the alumni network
      • Events
      • EM!L
      • MHH University Shop
      • Association
  • Career
    • Career
    • MHH training courses
    • MTR - Our diagnostics specialists with insight
    • Recruiting talent - for Nursing
      • Recruiting talent - for Nursing
      • Recruitment form
Welcome to the MHH News
Searched for "test". Found 66 results in 2 Millisekunden.

Filter by:

  • All content
  • Common content
  • Ambulances
  • News
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • »
News

Schizophrenia drug as new therapy against dementia

Relevance: 77%
 

the pathological accumulation of the tau protein. The effect of amisulpride has been successfully tested in various cellular models as well as in animal models of dementia. The results have now been published [...] Centre for Neurodegenerative Diseases in Magdeburg, we are preparing a Phase II clinical trial to test the effect of amisulpride in the treatment of patients with dementia," explains Professor Ponimaskin

News

Clinical trial to test new combination therapy against blood cancer

Relevance: 77%
 

similar approach in a new multicenter study. This will involve combining one of the drugs already being tested with another agent that has so far been used to treat anemia associated with chronic kidney disease [...] cultures and in mouse models. Now the efficacy, safety and tolerability of the new therapy are to be tested in a human clinical trial. Subjects are still being sought for this purpose. "We expect that treatment

News

Chronic Kidney Disease – Early Detection, Slowing Progression

Relevance: 75%
 

therefore frequently detected late. The lecture explains how to identify at-risk individuals , which tests are useful for early detection, and what measures help slow the progression of the disease—including

News

Fatty liver: The silent epidemic

Relevance: 75%
 

million have liver inflammation; and up to 1 million already have cirrhosis. Who needs which diagnostic tests, and what treatment options are available—ranging from a liver-healthy diet to newly approved medications

News

MHH: Immune booster helps with viral respiratory diseases

Relevance: 75%
 

research. Before new vaccines are launched on the market, they have to undergo extensive clinical testing. The requirements for a clinical trial are high, the bureaucratic effort for planning and implementation [...] with more than 2,000 participants aged 60 and older during the Corona pandemic at a total of twelve test centers nationwide and investigated the effect of VPM1002 vaccination on the clinical course of upper

News

MHH researcher wants to develop gene therapy against hearing and balance disorders

Relevance: 75%
 

it on the way. "We have already developed such an LV system in the iHEAR project and successfully tested it in the mouse model against hearing disorders and dizziness," the scientist notes. In the MY-O-SENSES [...] ve cure with the least amount of genetic material. If everything works, the gene therapy will be tested in clinical trials on humans at the end of the project. Professor Schambach is certain that the procedure

News

More impact against cancer

Relevance: 73%
 

impact,” says the molecular physician. In order to find the best CAR candidate, the researchers are testing various immune switches that, in addition to hyperactivation, are also supposed to prolong the survival [...] Schambach. If suitable candidates for the immune switches are found, the hyperactivated NK cells are tested for their efficacy and safety. This is done in cell culture, in surgically removed tumour tissue

News

New weapon against hepatitis D

Relevance: 73%
 

needed for this severe liver disease," emphasises the liver expert. In the current study, the drug was tested on a larger number of patients to see whether efficacy and safety could be confirmed in many different [...] existence, because for its continued existence in the body it must always infect new liver cells. "We tested the antiviral activity on 150 patients who were infected with both HBV and HDV," says Professor Cornberg

News

2.5 million euros for rapid therapies against viral diseases

Relevance: 72%
 

virus needs to replicate," says Professor Schambach. Effectiveness of RNAi candidates successfully tested in lung tissue RNAi technology uses molecular methods to target the Achilles' heel of viruses, so [...] development pipeline, this process could be shortened to just a few weeks. "We have successfully tested the efficacy and safety of our RNAi candidates on human lung tissue slices and in 3D cell cultures

News

Artificial lungs as organ replacement

Relevance: 72%
 

and emergency medicine specialist. Large area with the smallest possible volume The next step is to test whether the endothelial cells adhere firmly enough to the artificial surfaces and can withstand the [...] laboratory conditions using artificially generated blood circuits. In a next step, they will then be tested first as a respiratory acute aid and later as a permanent lung alternative in animal models. However

  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • »
Imprint Intranet Contact Privacy Accessibility

Information about

New MHH clinic building Academic career development Blood donation service Equality MHH Quality Report MHH-Alumni e.V. Baby gallery

Service

Patient Service Center Patient data requests GDPR Patient Advocate Feedback and complaint management ProBeweis - Confidential forensic evidence Campus life Fit for Work and Life

Follow us on

Facebook Instagram YouTube Xing LinkedIn
© 2019 - 2026 Medizinische Hochschule Hannover
Nach oben scrollen